Barbel Schmitt
Overview
Explore the profile of Barbel Schmitt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grigull N, Redeker J, Schmitt B, Saller M, Schonitzer V, Mayer-Wagner S
Int J Mol Sci
. 2020 Apr;
21(8).
PMID: 32316353
Cell-based approaches of cartilage lesions use different culture systems to obtain optimal cell quality. Pellet cultures with high cellular density (HD) are the gold standard to keep chondrocytes in a...
2.
Hofmann T, Schmitt B, Mack B, Lang S, Gires O, Zeidler R
Cancer Genomics Proteomics
. 2019 Aug;
1(2):167-176.
PMID: 31394681
Background: Tumor cells have developed several strategies to escape the immune system. One of these strategies consists of the secretion of immunosuppressive factors like interleukin-10 or prostaglandin E2 (PGE), which...
3.
Redeker J, Schmitt B, Grigull N, Braun C, Buttner A, Jansson V, et al.
BMC Complement Altern Med
. 2017 Aug;
17(1):402.
PMID: 28806939
Background: Studies of the effects of electromagnetic fields (EMFs) on cartilaginous cells show a broad range of outcomes. However EMFs are not yet clinically applied as standard treatment of osteoarthritis,...
4.
Mayer-Wagner S, Hammerschmid F, Redeker J, Schmitt B, Holzapfel B, Jansson V, et al.
Int Orthop
. 2014 Jul;
38(12):2615-21.
PMID: 25030964
Purpose: During in vitro chondrogenesis of human mesenchymal stem cells (hMSCs) hypertrophy is an inadvertent event associated with cell differentiation toward the osteogenic lineage. Up to now, there is no...
5.
Betz O, Betz V, Abdulazim A, Penzkofer R, Schmitt B, Schroder C, et al.
Tissue Eng Part A
. 2009 Dec;
16(3):1093-101.
PMID: 20035609
The repair of bone defects can be induced experimentally with bone morphogenetic protein-2 (BMP-2) producing fat-derived stem cells, but this ex vivo tissue engineering method requires the isolation and long-term...
6.
Betz O, Betz V, Abdulazim A, Penzkofer R, Schmitt B, Schroder C, et al.
Hum Gene Ther
. 2009 Jul;
20(12):1589-96.
PMID: 19572783
Numerous preclinical studies have shown that osseous defects can be repaired by implanting bone morphogenetic protein (BMP)-2-transduced muscle cells. However, the drawback of this treatment modality is that it requires...
7.
Munz M, Fellinger K, Hofmann T, Schmitt B, Gires O
Front Biosci
. 2008 May;
13:5195-201.
PMID: 18508581
Epithelial cell adhesion molecule EpCAM is strongly over-expressed in a variety of carcinomas where it is involved in signalling events resulting in increased expression of target genes such as c-Myc,...
8.
Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R
Anticancer Res
. 2006 Jun;
26(1B):783-9.
PMID: 16739354
Serological screening techniques, such as SEREX and AMIDA, use tumour-specific antibodies in the blood of patients to identify tumour-associated antigens. Using AMIDA, we have recently reported the identification of cytokeratin...
9.
Gires O, Andratschke M, Schmitt B, Mack B, Schaffrik M
Biochem Biophys Res Commun
. 2005 Feb;
328(4):1154-62.
PMID: 15707998
We reported the identification of tumour-associated antigens from head and neck carcinomas, including cytokeratin 8 (CK8). These antigens were isolated based on the humoral immune response they elicit in vivo...
10.
Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O
Oncogene
. 2004 Jun;
23(34):5748-58.
PMID: 15195135
Epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein expressed on adenomatous and simple epithelia, where it is involved in homophilic adhesion at the basolateral membrane. Carcinomas strongly overexpress EpCAM...